Showing 1 to 12 of 116 results
GLP-1 Agonists: Mechanisms of Weight Loss and Altered Taste Perception
New studies reveal that GLP-1 receptor agonists, like semaglutide and tirzepatide, induce weight loss in people with obesity by reducing appetite, slowing gastric emptying, increasing satiety, and altering taste perception, leading to reduced consumption of unhealthy foods.
GLP-1 Agonists: Mechanisms of Weight Loss and Altered Taste Perception
New studies reveal that GLP-1 receptor agonists, like semaglutide and tirzepatide, induce weight loss in people with obesity by reducing appetite, slowing gastric emptying, increasing satiety, and altering taste perception, leading to reduced consumption of unhealthy foods.
Progress
20% Bias Score
Orforglipron: A New Daily Pill for Weight Loss Shows Promising Results
A 72-week trial of 3,127 obese adults found that orforglipron, a new daily weight-loss pill, led to significant weight loss, with 18.4% of those on the highest dose losing 20% or more of their body weight.
Orforglipron: A New Daily Pill for Weight Loss Shows Promising Results
A 72-week trial of 3,127 obese adults found that orforglipron, a new daily weight-loss pill, led to significant weight loss, with 18.4% of those on the highest dose losing 20% or more of their body weight.
Progress
44% Bias Score
Study: Cutting Ultra-Processed Foods Leads to Significant Weight Loss
A two-month study published in Nature Medicine revealed that overweight adults who eliminated ultra-processed foods (UPFs) from their diets lost almost twice the weight compared to those who continued consuming UPFs.
Study: Cutting Ultra-Processed Foods Leads to Significant Weight Loss
A two-month study published in Nature Medicine revealed that overweight adults who eliminated ultra-processed foods (UPFs) from their diets lost almost twice the weight compared to those who continued consuming UPFs.
Progress
24% Bias Score
Mediterranean Diet, Exercise, and Support Prevent Type 2 Diabetes in Overweight and Obese Individuals
A new study shows that a low-calorie Mediterranean diet, combined with exercise and nutritional support, significantly reduced the risk of type 2 diabetes in overweight and obese individuals aged 55-75, with a 31% lower risk observed in the intervention group compared to those following the diet alo...
Mediterranean Diet, Exercise, and Support Prevent Type 2 Diabetes in Overweight and Obese Individuals
A new study shows that a low-calorie Mediterranean diet, combined with exercise and nutritional support, significantly reduced the risk of type 2 diabetes in overweight and obese individuals aged 55-75, with a 31% lower risk observed in the intervention group compared to those following the diet alo...
Progress
16% Bias Score
Weight-Loss Injections Reshape UK Wedding Dress Industry
The surge in popularity of weight-loss injections like Ozempic and Wegovy in the UK is causing significant challenges for bridal businesses, as brides' rapid weight loss necessitates expensive and time-consuming last-minute alterations.
Weight-Loss Injections Reshape UK Wedding Dress Industry
The surge in popularity of weight-loss injections like Ozempic and Wegovy in the UK is causing significant challenges for bridal businesses, as brides' rapid weight loss necessitates expensive and time-consuming last-minute alterations.
Progress
16% Bias Score
Mediterranean Diet Plus Lifestyle Changes Reduce Type 2 Diabetes Risk by 31%
A six-year study in Spain showed that combining a Mediterranean diet with calorie control, exercise, and professional support reduced the risk of type 2 diabetes by 31% in nearly 4,800 overweight or obese adults.
Mediterranean Diet Plus Lifestyle Changes Reduce Type 2 Diabetes Risk by 31%
A six-year study in Spain showed that combining a Mediterranean diet with calorie control, exercise, and professional support reduced the risk of type 2 diabetes by 31% in nearly 4,800 overweight or obese adults.
Progress
36% Bias Score
Oral Medication Shows Significant Weight Loss in Obesity Treatment
A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.
Oral Medication Shows Significant Weight Loss in Obesity Treatment
A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.
Progress
44% Bias Score
Insufficient NHS Funding Limits Mounjaro Access for Obesity
New research reveals that limited NHS funding will restrict access to the Mounjaro weight-loss jab for obesity to as few as one in five eligible people in England, despite 220,000 people being eligible over three years.
Insufficient NHS Funding Limits Mounjaro Access for Obesity
New research reveals that limited NHS funding will restrict access to the Mounjaro weight-loss jab for obesity to as few as one in five eligible people in England, despite 220,000 people being eligible over three years.
Progress
44% Bias Score
Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients
Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.
Mounjaro Price Hike Jeopardizes Mental Health Benefits for Weight Loss Patients
Sammi Hill, a 33-year-old mother of two from Nottingham, UK, regained her mental well-being and lost 4st (25.4kg) using Mounjaro, but a significant price increase threatens her continued access and the mental health of others.
Progress
40% Bias Score
Serena Williams' Weight Loss and the Pressure on Women's Appearance
Tennis star Serena Williams' significant weight loss, achieved through GLP-1 injections, highlights the societal pressures on women to conform to specific body ideals, irrespective of health or personal choice.
Serena Williams' Weight Loss and the Pressure on Women's Appearance
Tennis star Serena Williams' significant weight loss, achieved through GLP-1 injections, highlights the societal pressures on women to conform to specific body ideals, irrespective of health or personal choice.
Progress
64% Bias Score
Mediterranean Diet Significantly Reduces Type 2 Diabetes and Dementia Risk
Two large-scale studies show a Mediterranean diet combined with moderate calorie restriction and exercise reduces type 2 diabetes risk by 31% and slows cognitive decline, particularly benefiting those with a high genetic risk for Alzheimer's disease.
Mediterranean Diet Significantly Reduces Type 2 Diabetes and Dementia Risk
Two large-scale studies show a Mediterranean diet combined with moderate calorie restriction and exercise reduces type 2 diabetes risk by 31% and slows cognitive decline, particularly benefiting those with a high genetic risk for Alzheimer's disease.
Progress
44% Bias Score
Mediterranean Diet, Exercise, and Support Significantly Reduce Type 2 Diabetes Risk
A Spanish study (Predimed-Plus) involving 6,874 overweight to severely obese participants (55-75 years) demonstrated that a combined approach of a calorie-reduced Mediterranean diet, daily exercise, and professional weight-loss support resulted in a 31% lower risk of developing type 2 diabetes compa...
Mediterranean Diet, Exercise, and Support Significantly Reduce Type 2 Diabetes Risk
A Spanish study (Predimed-Plus) involving 6,874 overweight to severely obese participants (55-75 years) demonstrated that a combined approach of a calorie-reduced Mediterranean diet, daily exercise, and professional weight-loss support resulted in a 31% lower risk of developing type 2 diabetes compa...
Progress
20% Bias Score
Showing 1 to 12 of 116 results